Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amol N Patil

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Alimentary Pharmacology & Therapeutics|January 3, 2026
Clinical Trial: Long Versus Short Tapering of Steroids in Steroid Responsive Moderate to Severely Active Ulcerative Colitis-A Randomised Controlled TrialAnkit Kumar, Amol N Patil, Jyoti Grewal, et al.
Journal of Family Medicine and Primary Care|April 23, 2026
Prescription pattern assessment of pharmacotherapeutics used in the management of amyloidosis secondary to rheumatoid arthritis via systematic review and network meta-analysisAayush Sehgal, Muhammad A Shamim, Navpreet Kaur, et al.
Journal of Family Medicine and Primary Care|March 30, 2023
Comparison of master two-step exercise stress test versus six-min walk test in patients tested positive for SARS-CoV-2Ankit Kumar, Naveen Hegde, J Kumaravel, et al.
Blood Cell Therapy|December 9, 2024
A role for diet and gut microbiota metabolites in autologous hematopoietic cell transplant recipientsShaweta Kaundal, Amol N Patil, Lekshmon Ks, et al.
Blood Cell Therapy|December 9, 2024
Sirolimus as add-on therapy to corticosteroids for moderate-severe chronic graft versus host diseaseRitika Sharma, Andrew Pardeep, Renaissa De, et al.
Bone Marrow Transplantation|August 14, 2019
Impact of frailty, melphalan pharmacokinetics, and pharmacogenetics on outcomes post autologous hematopoietic cell transplantation for multiple myelomaRam V Nampoothiri, Kripa Shanker Kasudhan, Amol N Patil, et al.
Hematology/Oncology and Stem Cell Therapy|July 6, 2020
Long-term outcomes of innovator versus generic melphalan formulation in autologous hematopoietic cell transplantation for multiple myelomaDeepesh P Lad, Pankaj Malhotra, Amol N Patil, et al.
Alimentary Pharmacology & Therapeutics|November 21, 2025
Clinical Trial: Immunogenicity of Double-Dose Versus Standard-Dose of Hepatitis B Virus Vaccine in Inflammatory Bowel DiseaseAnupam Kumar Singh, Roop Kishor Soni, Vaneet Jearth, et al.
Journal of Ayurveda and Integrative Medicine|July 11, 2022
Essential oil nebulization in mild COVID-19(EONCO): Early phase exploratory clinical trialRamya Rathod, Ritin Mohindra, Akshay Vijayakumar, et al.
International Journal of Cancer|September 6, 2024
Aflatoxin exposure is associated with an increased risk of gallbladder cancerAmit Yadav, Pankaj Gupta, Parikshaa Gupta, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Alimentary Pharmacology & Therapeutics|January 3, 2026
Clinical Trial: Long Versus Short Tapering of Steroids in Steroid Responsive Moderate to Severely Active Ulcerative Colitis-A Randomised Controlled TrialAnkit Kumar, Amol N Patil, Jyoti Grewal, et al.
Journal of Family Medicine and Primary Care|April 23, 2026
Prescription pattern assessment of pharmacotherapeutics used in the management of amyloidosis secondary to rheumatoid arthritis via systematic review and network meta-analysisAayush Sehgal, Muhammad A Shamim, Navpreet Kaur, et al.
Journal of Family Medicine and Primary Care|March 30, 2023
Comparison of master two-step exercise stress test versus six-min walk test in patients tested positive for SARS-CoV-2Ankit Kumar, Naveen Hegde, J Kumaravel, et al.
Blood Cell Therapy|December 9, 2024
A role for diet and gut microbiota metabolites in autologous hematopoietic cell transplant recipientsShaweta Kaundal, Amol N Patil, Lekshmon Ks, et al.
Blood Cell Therapy|December 9, 2024
Sirolimus as add-on therapy to corticosteroids for moderate-severe chronic graft versus host diseaseRitika Sharma, Andrew Pardeep, Renaissa De, et al.
Bone Marrow Transplantation|August 14, 2019
Impact of frailty, melphalan pharmacokinetics, and pharmacogenetics on outcomes post autologous hematopoietic cell transplantation for multiple myelomaRam V Nampoothiri, Kripa Shanker Kasudhan, Amol N Patil, et al.
Hematology/Oncology and Stem Cell Therapy|July 6, 2020
Long-term outcomes of innovator versus generic melphalan formulation in autologous hematopoietic cell transplantation for multiple myelomaDeepesh P Lad, Pankaj Malhotra, Amol N Patil, et al.
Alimentary Pharmacology & Therapeutics|November 21, 2025
Clinical Trial: Immunogenicity of Double-Dose Versus Standard-Dose of Hepatitis B Virus Vaccine in Inflammatory Bowel DiseaseAnupam Kumar Singh, Roop Kishor Soni, Vaneet Jearth, et al.
Journal of Ayurveda and Integrative Medicine|July 11, 2022
Essential oil nebulization in mild COVID-19(EONCO): Early phase exploratory clinical trialRamya Rathod, Ritin Mohindra, Akshay Vijayakumar, et al.
International Journal of Cancer|September 6, 2024
Aflatoxin exposure is associated with an increased risk of gallbladder cancerAmit Yadav, Pankaj Gupta, Parikshaa Gupta, et al.
Pageof 6